Gregory M Cote (Gregory Cote)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Science advances

Cancer

Massachusetts General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts General Hospital Jul 01 2012

United States

Physician :: Hematology/Oncology

Publications

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola, Vinayak Venkataraman, Thierry Alcindor, Andrew J Wagner, George D Demetri, Suzanne George
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola, Vinayak Venkataraman, Thierry Alcindor, Andrew J Wagner, George D Demetri, Suzanne George
Safety And Efficacy Of Combination Lurbinectedin Plus Doxorubicin From A Phase 1b Trial In Patients With Advanced/Metastatic Soft Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Zehra Ordulu, Peter Giunta, Wei-Ting Hung, Yin Pun Hung, Judit Simon, Florian J Fintelmann, Jochen K Lennerz, Kamila Naxerova, Gregory M Cote
Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired ALK Rearrangement. JCO precision oncology 7 (2023)
Vinayak Venkataraman, Suzanne George, Gregory M Cote
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor. The oncologist (2023)
Zehra Ordulu, Peter Giunta, Wei-Ting Hung, Yin Pun Hung, Judit Simon, Florian J Fintelmann, Jochen K Lennerz, Kamila Naxerova, Gregory M Cote
Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired ALK Rearrangement. JCO precision oncology 7 (2023)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Zehra Ordulu, Peter Giunta, Wei-Ting Hung, Yin Pun Hung, Judit Simon, Florian J Fintelmann, Jochen K Lennerz, Kamila Naxerova, Gregory M Cote
Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired ALK Rearrangement. JCO precision oncology 7 (2023)
Rajendran Sanalkumar, Rui Dong, Lukuo Lee, Yu-Hang Xing, Sowmya Iyer, Igor Letovanec, Stefano La Rosa, Giovanna Finzi, Elettra Musolino, Roberto Papait, Ivan A Chebib, G Petur Nielsen, Raffaele Renella, Gregory M Cote, Edwin Choy, Martin J Aryee, Kimberly Stegmaier, Ivan Stamenkovic, Miguel N Rivera, Nicolò Riggi
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity. Science advances 9 (13) (2023)
Rajendran Sanalkumar, Rui Dong, Lukuo Lee, Yu-Hang Xing, Sowmya Iyer, Igor Letovanec, Stefano La Rosa, Giovanna Finzi, Elettra Musolino, Roberto Papait, Ivan A Chebib, G Petur Nielsen, Raffaele Renella, Gregory M Cote, Edwin Choy, Martin J Aryee, Kimberly Stegmaier, Ivan Stamenkovic, Miguel N Rivera, Nicolò Riggi
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity. Science advances 9 (13) (2023)
Zehra Ordulu, Peter Giunta, Wei-Ting Hung, Yin Pun Hung, Judit Simon, Florian J Fintelmann, Jochen K Lennerz, Kamila Naxerova, Gregory M Cote
Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired ALK Rearrangement. JCO precision oncology 7 (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A single-arm phase 2 trial of Sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Santiago A Lozano Calderón, Jose Ignacio Albergo, Olivier Q Groot, Nelson A Merchan, Jad M El Abiad, Vanessa Salinas, Luis Carlos Gomez Mier, Camilo Soto Montoya, Marco L Ferrone, John E Ready, Francisco J Linares, Adam S Levin, Manuel Peleteiro Pensado, José Juan Pozo Kreilinger, Irene Barrientos Ruiz, Eduardo J Ortiz-Cruz, Mark C Gebhardt, Gregory M Cote, Edwin Choy, Dimitrios Spentzos, Yin Pun Hung, Vikram Deshpande, Ivan A Chebib, Robert Allan McCulloch, Germán Farfalli, Luis Aponte Tinao, Carol D Morris, Gunnlaugur Petur Nielsen, Megan E Anderson, Lee M Jeys
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma. Cancer (2022)
Ingo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, Howard A Burris, Elizabeth A Maher, Filip Janku, Gregory M Cote, Macarena I de la Fuente, Jennifer L Clarke, Benjamin M Ellingson, Saewon Chun, Robert J Young, Hua Liu, Sung Choe, Min Lu, Kha Le, Islam Hassan, Lori Steelman, Shuchi S Pandya, Timothy F Cloughesy, Patrick Y Wen
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
William D Tap, Arun S Singh, Stephen Patrick Anthony, Mike Sterba, Chao Zhang, John H Healey, Bartosz Chmielowski, Allen Lee Cohn, Geoffrey I Shapiro, Vicki L Keedy, Zev A Wainberg, Igor Puzanov, Gregory M Cote, Andrew J Wagner, Fadi Braiteh, Eric Sherman, Henry H Hsu, Charles Peterfy, Heather L Gelhorn, Xin Ye, Paul Severson, Brian L West, Paul S Lin, Sandra Tong-Starksen
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Gaylor Boulay, Luisa Cironi, Sara P Garcia, Shruthi Rengarajan, Yu-Hang Xing, Lukuo Lee, Mary E Awad, Beverly Naigles, Sowmya Iyer, Liliane C Broye, Tugba Keskin, Alexandra Cauderay, Carlo Fusco, Igor Letovanec, Ivan Chebib, Petur Gunnalugur Nielsen, Stephane Tercier, Stephane Cherix, Tu Nguyen-Ngoc, Gregory M Cote, Edwin Choy, Paolo Provero, Mario L Suvà, Miguel N Rivera, Ivan Stamenkovic, Nicolò Riggi
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies. Life science alliance 4 (2) (2020)
Ruoyu Miao, Edwin Choy, Kevin A Raskin, Joseph H Schwab, Gunnlaugur Petur Nielsen, Vikram Deshpande, Ivan A Chebib, Thomas F DeLaney, Francis J Hornicek, Gregory M Cote, Yen-Lin E Chen
Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma 2019 (2019)

Gregory M Cote.css-eqlu8i{font-size:small;padding-left:4px;} (Gregory Cote)

Publication Activity (10 Years)

Top Topics

Top Venues

Gregory M Cote (Gregory Cote)